Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syndros for bone pain in breast cancer
NCT03661892Phase 1Completed
- Sponsor
- University of Arizona
- Start
- Dec 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dronabinol in pain, sponsored by University of Arizona. Primary endpoint: Need for opiate pain medication at 8 weeks. Started Dec 2018; status: completed.
02
Drugs
dronabinol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03661892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03661892.